Double-blind, multicenter comparative study of sertraline versus amitriptyline in outpatients with major depression

Pharmacopsychiatry

Volumn 33, Issue 6, 2000, Pages 206-212

  Moller H J ^a   Glaser, K ^b   Leverkus, F ^c   Gobel C ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Institute for Psychodiagnostics Psychosomatics and Behavioral Medicine   (Germany)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GERMANY; HAMILTON SCALE; HUMAN; MULTICENTER STUDY; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; SERTRALINE; TREATMENT OUTCOME;

EID: 0033675614     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-8357     Document Type: Article

References (32)

1. Life satisfaction and psychosocial functioning in chronic depression: Effect of acute treatment with antidepressant
2. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression
3. The efficacy of selective serotonin re-uptake inhibitors in depression: A meta-analysis of studies against tricyclic anitdepressants
4. Quantitative rating of depressive states
5. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression
6. Blockade by newly-developed anti-depressants of biogenic amine uptake into rat brain synaptosomes
7. The application of REML in clinical trials
8. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients
9. Some general methods for the analysis of categorical data in longitudinal studies
10. A double-blind placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice
11. Sertraline in the treatment of panic disorder: A multi-site, double-blind, placebo-controlled fixed-dose investigation
12. Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo
13. Morbidity of clinical depression
14. Multifokale Psychopharmakaprufung (Multihospital Trial)
15. A double-blind comparison of sertraline and imipramine in outpatients with major depression. Acute (8 weeks) and continuation (16 weeks) treatment
16. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder
17. A rating scale for depression
18. Comparative pharmacology of selective serotonin reuptake inhibitors (SSRIs)
19. Long-term outcome of depressive illness
20. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of Major Depression
21. Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with Major Depression
22. Why do amitriptyline and dothiepin appear to be so dangerous in overdose?
23. Sertraline: Efficacy and toleration in major depression
24. Sertraline 50 mg daily: The optimal dose in the treatment of depression
25. Antidepressant efficacy of sertraline: A double-blind, placebo and amitriptyline-controlled, multicenter comparison study in outpatients with major depression
26. The use of restricted significance test in clinical trials
27. Dosing strategies for antidepressant agents
28. Facet theroretic analysis of the Hamilton-D scale
29. The oral dose-effect relationship for fluvoxamine: A fixed-dose comparison against placebo in depressed outpatients
30. 072 DSI. Depression status inventory
31. 073 SDS. Self-rating depression scale